ArticleCase reports in ophthalmology
Pattern Electroretinogram in Glaucoma Suspects with Signs of Conversion: Diagnosis, Assessment, and Monitoring Treatment - Case Report.
Article in Case reports in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The purpose of this case report was to describe a case of a 61-year-old female glaucoma suspect with signs of conversion into early glaucoma. Treatment with prostaglandin analog drops was started. Case Presentation: A 61-year-old female presented with worsening vision in the left eye, elevated intraocular pressure (IOP) of 25 mm Hg in the right eye and 21 mm Hg in the left eye. Humphrey visual field tests showed borderline glaucomatous changes, but pattern electroretinogram (PERG) confirmed objective retinal ganglion cell (RGC) dysfunction in both eyes. Prostaglandin analog drops were offered to be used daily, but the patient preferred to use the drops 3 times per week. PERG was conducted during her next 3 follow-up visits, demonstrating reductions of the IOP lowering effects on PERG parameters when the drops were not instilled consistently. Estimated RGC count significantly increased after IOP lowering treatment. Conclusion: The effects of the prostaglandin analog treatment have demonstrated improvements in PERG parameters, demonstrating a restoration of RGC function and an increase in the estimated RGC count, based on the combined structure-function index. However, when the treatment was not applied consistently as prescribed, and when longer periods of nontreatment occurred, PERG parameters transiently deteriorated, demonstrating the presence of a transient RGC dysfunction state. PERG demonstrates the potential in monitoring the effectiveness of IOP lowering treatment in newly diagnosed subjects for not only chronic IOP elevation, but for transient IOP elevation detections as well. This could be mostly due to either lack of adherence, skipping treatment, delayed access to prescription refills, or missing timely drop instillations due to forgetfulness or travel.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.